附件2.英方企业简介及概要.docVIP

附件2. 英方企业简介 出席人员：首席执行官 麦克·瑞沃希博士 Neotherix是一家做再生药物的公司，开发帮助组织再生和修复的新型生物可吸收支架。Neotherix针对人体软组织的修复和治疗研发了创新产品，这些产品能满足临床需求。他们结合伤口生物处理探索了一个独一无二的聚合物静电技术，并证实了生物可吸收支架的有效性。Neotherix公司在常州举办的中英科技桥活动中给予了大力支持，现在他们倾向为更多再生医药公司（包括RegeNer8公司，一个结合英国本土企业和学术机构的大型联盟）挖掘在广州的合作机会。 Neotherix is a regenerative medicine company specialising in the development of novel bioresorbable scaffolds for tissue regeneration and repair. Neotherix develops innovative products for soft tissue repair and therapy in specific, selected applications where there is a clear clinical need. They apply and exploit a unique knowledge of polymer electrospinning technology combined with wound healing biology to develop and then demonstrate the effectiveness of the resulting bioresorbable scaffold materials. Neotherix have been strong supporters of the UK-China open innovation programme in Changzhou, and are keen to explore new opportunities for regenerative medicine companies (including RegeNer8, a large consortium of UK-based companies and academic centres) in Guangzhou. 出席人员：琼安·Edixomed is developing a novel nitric oxide-generating technology with a broad clinical application in a wide variety of diseases. Edixomed are working on a nitric oxide dressing for diabetic patients with chronic leg ulcers to enable rapid healing. The system delivers nitric oxide directly to the target tissues, helping to increase blood flow and stimulate wound healing. Edixomed is a clinical stage biotechnology portfolio company of Alida Capital International, an investment company specialising in the Life Science sector. Following initial support, Edixomed is now enjoying rapid growth. 出席人员：商业开发总监 杰森·金Giltech is an international company creating bespoke formulations of its biodegradable and controlled release technologies with broad application. With 25 years of expertise, Giltech technologies have been used to produce pioneering products including Sorbsan? and Arglaes? and CorGlaes?, a water soluble glass. Its current activities focu